Prevalence of Osteoporosis Assessed by DXA and/or CT in Severe Obese Patients.
bone mineral density (BMD)
dual-energy X-ray absorptiometry (DXA)
obesity
scanographic bone attenuation coefficient (SBAC-L1)
tomodensitometry/CT
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
17 Oct 2022
17 Oct 2022
Historique:
received:
02
09
2022
revised:
07
10
2022
accepted:
15
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
The primary objective was to evaluate bone fragility prevalence on dual X-ray absorptiometry (DXA) and computed tomography (CT) in patients with severe obesity. The secondary objective was to evaluate the risk factors for bone fragility. This monocentric study was conducted in patients with grade 2 and 3 obesity. Bone mineral density (BMD) and T-score were studied on DXA, and the scanographic bone attenuation coefficient of L1 (SBAC-L1) was measured on CT. Among the 1386 patients included, 1013 had undergone both DXA and CT within less than 2 years. The mean age was 48.4 (±11.4) years, 77.6% were women, and the mean BMI was 45.6 (±6.7) kg/m². Eight patients (0.8%) had osteoporosis in at least one site. The mean SBAC-L1 was 192.3 (±52.4) HU; 163 patients (16.1%) were under the threshold of 145 HU. Older age (OR[CI95] = 1.1 [1.08-1.16]), lower BMD on the femoral neck and spine (OR[CI95] = 0.04[0.005-0.33] and OR[CI95] = 0.001[0.0001-0.008], respectively), and higher lean mass (OR[CI95] = 1.1 [1.03-1.13]) were significantly associated with an SBAC-L1 ≤ 145 HU in multivariate analysis. Approximately 16% of patients with severe obesity were under the SBAC-L1 threshold, while less than 1% were classified as osteoporotic on DXA.
Identifiants
pubmed: 36294434
pii: jcm11206114
doi: 10.3390/jcm11206114
pmc: PMC9605130
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Obes Rev. 2018 May;19(5):728-736
pubmed: 29334691
Rheumatol Int. 2018 Oct;38(10):1901-1910
pubmed: 30132216
Sci Rep. 2019 Sep 16;9(1):13323
pubmed: 31527613
J Bone Miner Res. 2014 Jul;29(7):1507-18
pubmed: 24677277
J Bone Miner Res. 2014 Jan;29(1):223-33
pubmed: 23775829
J Bone Miner Res. 1993 Sep;8(9):1137-48
pubmed: 8237484
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Joint Bone Spine. 2018 Oct;85(5):519-530
pubmed: 29654947
Yonsei Med J. 2010 Nov;51(6):857-63
pubmed: 20879051
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4756-4768
pubmed: 30901056
Obes Surg. 2012 Apr;22(4):654-67
pubmed: 22271358
Osteoporos Int. 2019 Jun;30(6):1215-1222
pubmed: 30868182
Osteoporos Int. 2018 Jan;29(1):31-39
pubmed: 29098347
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Int J Clin Pract. 2014 Jun;68(6):771-4
pubmed: 24447370
World Health Organ Tech Rep Ser. 1994;843:1-129
pubmed: 7941614
Int J Clin Pract. 2010 May;64(6):817-20
pubmed: 20518955
Am J Clin Nutr. 2006 Jan;83(1):146-54
pubmed: 16400063
Radiology. 2019 May;291(2):360-367
pubmed: 30912719
Br J Radiol. 2019 Feb;92(1094):20180726
pubmed: 30433815
Osteoporos Int. 2014 Jan;25(1):85-95
pubmed: 23884437
Curr Obes Rep. 2016 Mar;5(1):30-7
pubmed: 26830309
J Bone Miner Res. 2010 Feb;25(2):292-7
pubmed: 19821769
Obesity (Silver Spring). 2013 Mar;21 Suppl 1:S1-27
pubmed: 23529939
Ann Intern Med. 2013 Apr 16;158(8):588-95
pubmed: 23588747
Orthopedics. 2010 Jun;33(6):422-9
pubmed: 20806752